Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Enoxaparin Sodium Injection Market Growth 2022-2028

  • LP 4893015
  • 119 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Enoxaparin Sodium Injection will have significant change from previous year. According to our (LP Information) latest study, the global Enoxaparin Sodium Injection market size is USD million in 2022 from USD 2978.3 million in 2021, with a change of % between 2021 and 2022. The global Enoxaparin Sodium Injection market size will reach USD 5249.5 million in 2028, growing at a CAGR of 8.4% over the analysis period.

The United States Enoxaparin Sodium Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Enoxaparin Sodium Injection market, reaching US$ million by the year 2028. As for the Europe Enoxaparin Sodium Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Enoxaparin Sodium Injection players cover Sanofi, Fresenius Kabi, Rovi, and Amphastar, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi

Fresenius Kabi

Rovi

Amphastar

Teva

Nanjing King-friend

Techdow (Hepalink)

Sandoz

Apotex

Cipla

Taj Pharma

Hangzhou Jiuyuan Gene Engineering

Chengdu Baiyu Pharmaceutical

Hebei Changshan Biochemical Pharmaceutical

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Suzhou Erye Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Enoxaparin Sodium Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Enoxaparin Sodium Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Enoxaparin Sodium Injection by Country/Region, 2017, 2022 & 2028

2.2 Enoxaparin Sodium Injection Segment by Type

2.2.1 20 mg/0.2mL

2.2.2 30 mg/0.3mL

2.2.3 40 mg/0.4mL

2.2.4 60 mg/0.6mL

2.2.5 80 mg/0.8mL

2.2.6 100 mg/1mL

2.2.7 120 mg/0.8mL

2.2.8 150 mg/1mL

2.2.9 300mg/3mL

2.3 Enoxaparin Sodium Injection Sales by Type

2.3.1 Global Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Enoxaparin Sodium Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Enoxaparin Sodium Injection Sale Price by Type (2017-2022)

2.4 Enoxaparin Sodium Injection Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Enoxaparin Sodium Injection Sales by Application

2.5.1 Global Enoxaparin Sodium Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Enoxaparin Sodium Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Enoxaparin Sodium Injection Sale Price by Application (2017-2022)

3 Global Enoxaparin Sodium Injection by Company

3.1 Global Enoxaparin Sodium Injection Breakdown Data by Company

3.1.1 Global Enoxaparin Sodium Injection Annual Sales by Company (2020-2022)

3.1.2 Global Enoxaparin Sodium Injection Sales Market Share by Company (2020-2022)

3.2 Global Enoxaparin Sodium Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Enoxaparin Sodium Injection Revenue by Company (2020-2022)

3.2.2 Global Enoxaparin Sodium Injection Revenue Market Share by Company (2020-2022)

3.3 Global Enoxaparin Sodium Injection Sale Price by Company

3.4 Key Manufacturers Enoxaparin Sodium Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Enoxaparin Sodium Injection Product Location Distribution

3.4.2 Players Enoxaparin Sodium Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Enoxaparin Sodium Injection by Geographic Region

4.1 World Historic Enoxaparin Sodium Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Enoxaparin Sodium Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Enoxaparin Sodium Injection Annual Revenue by Geographic Region

4.2 World Historic Enoxaparin Sodium Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Enoxaparin Sodium Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Enoxaparin Sodium Injection Annual Revenue by Country/Region

4.3 Americas Enoxaparin Sodium Injection Sales Growth

4.4 APAC Enoxaparin Sodium Injection Sales Growth

4.5 Europe Enoxaparin Sodium Injection Sales Growth

4.6 Middle East & Africa Enoxaparin Sodium Injection Sales Growth

5 Americas

5.1 Americas Enoxaparin Sodium Injection Sales by Country

5.1.1 Americas Enoxaparin Sodium Injection Sales by Country (2017-2022)

5.1.2 Americas Enoxaparin Sodium Injection Revenue by Country (2017-2022)

5.2 Americas Enoxaparin Sodium Injection Sales by Type

5.3 Americas Enoxaparin Sodium Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Enoxaparin Sodium Injection Sales by Region

6.1.1 APAC Enoxaparin Sodium Injection Sales by Region (2017-2022)

6.1.2 APAC Enoxaparin Sodium Injection Revenue by Region (2017-2022)

6.2 APAC Enoxaparin Sodium Injection Sales by Type

6.3 APAC Enoxaparin Sodium Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Enoxaparin Sodium Injection by Country

7.1.1 Europe Enoxaparin Sodium Injection Sales by Country (2017-2022)

7.1.2 Europe Enoxaparin Sodium Injection Revenue by Country (2017-2022)

7.2 Europe Enoxaparin Sodium Injection Sales by Type

7.3 Europe Enoxaparin Sodium Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Enoxaparin Sodium Injection by Country

8.1.1 Middle East & Africa Enoxaparin Sodium Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Enoxaparin Sodium Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Enoxaparin Sodium Injection Sales by Type

8.3 Middle East & Africa Enoxaparin Sodium Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Enoxaparin Sodium Injection

10.3 Manufacturing Process Analysis of Enoxaparin Sodium Injection

10.4 Industry Chain Structure of Enoxaparin Sodium Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Enoxaparin Sodium Injection Distributors

11.3 Enoxaparin Sodium Injection Customer

12 World Forecast Review for Enoxaparin Sodium Injection by Geographic Region

12.1 Global Enoxaparin Sodium Injection Market Size Forecast by Region

12.1.1 Global Enoxaparin Sodium Injection Forecast by Region (2023-2028)

12.1.2 Global Enoxaparin Sodium Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Enoxaparin Sodium Injection Forecast by Type

12.7 Global Enoxaparin Sodium Injection Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Enoxaparin Sodium Injection Product Offered

13.1.3 Sanofi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Fresenius Kabi

13.2.1 Fresenius Kabi Company Information

13.2.2 Fresenius Kabi Enoxaparin Sodium Injection Product Offered

13.2.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Fresenius Kabi Main Business Overview

13.2.5 Fresenius Kabi Latest Developments

13.3 Rovi

13.3.1 Rovi Company Information

13.3.2 Rovi Enoxaparin Sodium Injection Product Offered

13.3.3 Rovi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Rovi Main Business Overview

13.3.5 Rovi Latest Developments

13.4 Amphastar

13.4.1 Amphastar Company Information

13.4.2 Amphastar Enoxaparin Sodium Injection Product Offered

13.4.3 Amphastar Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amphastar Main Business Overview

13.4.5 Amphastar Latest Developments

13.5 Teva

13.5.1 Teva Company Information

13.5.2 Teva Enoxaparin Sodium Injection Product Offered

13.5.3 Teva Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Teva Main Business Overview

13.5.5 Teva Latest Developments

13.6 Nanjing King-friend

13.6.1 Nanjing King-friend Company Information

13.6.2 Nanjing King-friend Enoxaparin Sodium Injection Product Offered

13.6.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Nanjing King-friend Main Business Overview

13.6.5 Nanjing King-friend Latest Developments

13.7 Techdow (Hepalink)

13.7.1 Techdow (Hepalink) Company Information

13.7.2 Techdow (Hepalink) Enoxaparin Sodium Injection Product Offered

13.7.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Techdow (Hepalink) Main Business Overview

13.7.5 Techdow (Hepalink) Latest Developments

13.8 Sandoz

13.8.1 Sandoz Company Information

13.8.2 Sandoz Enoxaparin Sodium Injection Product Offered

13.8.3 Sandoz Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sandoz Main Business Overview

13.8.5 Sandoz Latest Developments

13.9 Apotex

13.9.1 Apotex Company Information

13.9.2 Apotex Enoxaparin Sodium Injection Product Offered

13.9.3 Apotex Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Apotex Main Business Overview

13.9.5 Apotex Latest Developments

13.10 Cipla

13.10.1 Cipla Company Information

13.10.2 Cipla Enoxaparin Sodium Injection Product Offered

13.10.3 Cipla Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cipla Main Business Overview

13.10.5 Cipla Latest Developments

13.11 Taj Pharma

13.11.1 Taj Pharma Company Information

13.11.2 Taj Pharma Enoxaparin Sodium Injection Product Offered

13.11.3 Taj Pharma Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Taj Pharma Main Business Overview

13.11.5 Taj Pharma Latest Developments

13.12 Hangzhou Jiuyuan Gene Engineering

13.12.1 Hangzhou Jiuyuan Gene Engineering Company Information

13.12.2 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Offered

13.12.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview

13.12.5 Hangzhou Jiuyuan Gene Engineering Latest Developments

13.13 Chengdu Baiyu Pharmaceutical

13.13.1 Chengdu Baiyu Pharmaceutical Company Information

13.13.2 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Offered

13.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Chengdu Baiyu Pharmaceutical Main Business Overview

13.13.5 Chengdu Baiyu Pharmaceutical Latest Developments

13.14 Hebei Changshan Biochemical Pharmaceutical

13.14.1 Hebei Changshan Biochemical Pharmaceutical Company Information

13.14.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Offered

13.14.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Hebei Changshan Biochemical Pharmaceutical Main Business Overview

13.14.5 Hebei Changshan Biochemical Pharmaceutical Latest Developments

13.15 Changzhou Qianhong Bio-pharma

13.15.1 Changzhou Qianhong Bio-pharma Company Information

13.15.2 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Offered

13.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Changzhou Qianhong Bio-pharma Main Business Overview

13.15.5 Changzhou Qianhong Bio-pharma Latest Developments

13.16 Beijing SL Pharmaceutical

13.16.1 Beijing SL Pharmaceutical Company Information

13.16.2 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Offered

13.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Beijing SL Pharmaceutical Main Business Overview

13.16.5 Beijing SL Pharmaceutical Latest Developments

13.17 Suzhou Erye Pharmaceutical

13.17.1 Suzhou Erye Pharmaceutical Company Information

13.17.2 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Offered

13.17.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Suzhou Erye Pharmaceutical Main Business Overview

13.17.5 Suzhou Erye Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Enoxaparin Sodium Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Enoxaparin Sodium Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 20 mg/0.2mL

Table 4. Major Players of 30 mg/0.3mL

Table 5. Major Players of 40 mg/0.4mL

Table 6. Major Players of 60 mg/0.6mL

Table 7. Major Players of 80 mg/0.8mL

Table 8. Major Players of 100 mg/1mL

Table 9. Major Players of 120 mg/0.8mL

Table 10. Major Players of 150 mg/1mL

Table 11. Major Players of 300mg/3mL

Table 12. Global Enoxaparin Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 13. Global Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

Table 14. Global Enoxaparin Sodium Injection Revenue by Type (2017-2022) & ($ million)

Table 15. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2017-2022)

Table 16. Global Enoxaparin Sodium Injection Sale Price by Type (2017-2022) & (US$/Unit)

Table 17. Global Enoxaparin Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 18. Global Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Table 19. Global Enoxaparin Sodium Injection Revenue by Application (2017-2022)

Table 20. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2017-2022)

Table 21. Global Enoxaparin Sodium Injection Sale Price by Application (2017-2022) & (US$/Unit)

Table 22. Global Enoxaparin Sodium Injection Sales by Company (2020-2022) & (K Units)

Table 23. Global Enoxaparin Sodium Injection Sales Market Share by Company (2020-2022)

Table 24. Global Enoxaparin Sodium Injection Revenue by Company (2020-2022) ($ Millions)

Table 25. Global Enoxaparin Sodium Injection Revenue Market Share by Company (2020-2022)

Table 26. Global Enoxaparin Sodium Injection Sale Price by Company (2020-2022) & (US$/Unit)

Table 27. Key Manufacturers Enoxaparin Sodium Injection Producing Area Distribution and Sales Area

Table 28. Players Enoxaparin Sodium Injection Products Offered

Table 29. Enoxaparin Sodium Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 30. New Products and Potential Entrants

Table 31. Mergers & Acquisitions, Expansion

Table 32. Global Enoxaparin Sodium Injection Sales by Geographic Region (2017-2022) & (K Units)

Table 33. Global Enoxaparin Sodium Injection Sales Market Share Geographic Region (2017-2022)

Table 34. Global Enoxaparin Sodium Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 35. Global Enoxaparin Sodium Injection Revenue Market Share by Geographic Region (2017-2022)

Table 36. Global Enoxaparin Sodium Injection Sales by Country/Region (2017-2022) & (K Units)

Table 37. Global Enoxaparin Sodium Injection Sales Market Share by Country/Region (2017-2022)

Table 38. Global Enoxaparin Sodium Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 39. Global Enoxaparin Sodium Injection Revenue Market Share by Country/Region (2017-2022)

Table 40. Americas Enoxaparin Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 41. Americas Enoxaparin Sodium Injection Sales Market Share by Country (2017-2022)

Table 42. Americas Enoxaparin Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 43. Americas Enoxaparin Sodium Injection Revenue Market Share by Country (2017-2022)

Table 44. Americas Enoxaparin Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 45. Americas Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

Table 46. Americas Enoxaparin Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 47. Americas Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Table 48. APAC Enoxaparin Sodium Injection Sales by Region (2017-2022) & (K Units)

Table 49. APAC Enoxaparin Sodium Injection Sales Market Share by Region (2017-2022)

Table 50. APAC Enoxaparin Sodium Injection Revenue by Region (2017-2022) & ($ Millions)

Table 51. APAC Enoxaparin Sodium Injection Revenue Market Share by Region (2017-2022)

Table 52. APAC Enoxaparin Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 53. APAC Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

Table 54. APAC Enoxaparin Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 55. APAC Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Table 56. Europe Enoxaparin Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 57. Europe Enoxaparin Sodium Injection Sales Market Share by Country (2017-2022)

Table 58. Europe Enoxaparin Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 59. Europe Enoxaparin Sodium Injection Revenue Market Share by Country (2017-2022)

Table 60. Europe Enoxaparin Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 61. Europe Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

Table 62. Europe Enoxaparin Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 63. Europe Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Table 64. Middle East & Africa Enoxaparin Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 65. Middle East & Africa Enoxaparin Sodium Injection Sales Market Share by Country (2017-2022)

Table 66. Middle East & Africa Enoxaparin Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 67. Middle East & Africa Enoxaparin Sodium Injection Revenue Market Share by Country (2017-2022)

Table 68. Middle East & Africa Enoxaparin Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 69. Middle East & Africa Enoxaparin Sodium Injection Sales Market Share by Type (2017-2022)

Table 70. Middle East & Africa Enoxaparin Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 71. Middle East & Africa Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Table 72. Key Market Drivers & Growth Opportunities of Enoxaparin Sodium Injection

Table 73. Key Market Challenges & Risks of Enoxaparin Sodium Injection

Table 74. Key Industry Trends of Enoxaparin Sodium Injection

Table 75. Enoxaparin Sodium Injection Raw Material

Table 76. Key Suppliers of Raw Materials

Table 77. Enoxaparin Sodium Injection Distributors List

Table 78. Enoxaparin Sodium Injection Customer List

Table 79. Global Enoxaparin Sodium Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 80. Global Enoxaparin Sodium Injection Sales Market Forecast by Region

Table 81. Global Enoxaparin Sodium Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Global Enoxaparin Sodium Injection Revenue Market Share Forecast by Region (2023-2028)

Table 83. Americas Enoxaparin Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Americas Enoxaparin Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. APAC Enoxaparin Sodium Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 86. APAC Enoxaparin Sodium Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 87. Europe Enoxaparin Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 88. Europe Enoxaparin Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Middle East & Africa Enoxaparin Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 90. Middle East & Africa Enoxaparin Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 91. Global Enoxaparin Sodium Injection Sales Forecast by Type (2023-2028) & (K Units)

Table 92. Global Enoxaparin Sodium Injection Sales Market Share Forecast by Type (2023-2028)

Table 93. Global Enoxaparin Sodium Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 94. Global Enoxaparin Sodium Injection Revenue Market Share Forecast by Type (2023-2028)

Table 95. Global Enoxaparin Sodium Injection Sales Forecast by Application (2023-2028) & (K Units)

Table 96. Global Enoxaparin Sodium Injection Sales Market Share Forecast by Application (2023-2028)

Table 97. Global Enoxaparin Sodium Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 98. Global Enoxaparin Sodium Injection Revenue Market Share Forecast by Application (2023-2028)

Table 99. Sanofi Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi Enoxaparin Sodium Injection Product Offered

Table 101. Sanofi Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Sanofi Main Business

Table 103. Sanofi Latest Developments

Table 104. Fresenius Kabi Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 105. Fresenius Kabi Enoxaparin Sodium Injection Product Offered

Table 106. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Fresenius Kabi Main Business

Table 108. Fresenius Kabi Latest Developments

Table 109. Rovi Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 110. Rovi Enoxaparin Sodium Injection Product Offered

Table 111. Rovi Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Rovi Main Business

Table 113. Rovi Latest Developments

Table 114. Amphastar Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 115. Amphastar Enoxaparin Sodium Injection Product Offered

Table 116. Amphastar Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Amphastar Main Business

Table 118. Amphastar Latest Developments

Table 119. Teva Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 120. Teva Enoxaparin Sodium Injection Product Offered

Table 121. Teva Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Teva Main Business

Table 123. Teva Latest Developments

Table 124. Nanjing King-friend Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 125. Nanjing King-friend Enoxaparin Sodium Injection Product Offered

Table 126. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Nanjing King-friend Main Business

Table 128. Nanjing King-friend Latest Developments

Table 129. Techdow (Hepalink) Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 130. Techdow (Hepalink) Enoxaparin Sodium Injection Product Offered

Table 131. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Techdow (Hepalink) Main Business

Table 133. Techdow (Hepalink) Latest Developments

Table 134. Sandoz Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 135. Sandoz Enoxaparin Sodium Injection Product Offered

Table 136. Sandoz Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Sandoz Main Business

Table 138. Sandoz Latest Developments

Table 139. Apotex Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 140. Apotex Enoxaparin Sodium Injection Product Offered

Table 141. Apotex Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Apotex Main Business

Table 143. Apotex Latest Developments

Table 144. Cipla Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 145. Cipla Enoxaparin Sodium Injection Product Offered

Table 146. Cipla Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Cipla Main Business

Table 148. Cipla Latest Developments

Table 149. Taj Pharma Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 150. Taj Pharma Enoxaparin Sodium Injection Product Offered

Table 151. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Taj Pharma Main Business

Table 153. Taj Pharma Latest Developments

Table 154. Hangzhou Jiuyuan Gene Engineering Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 155. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Offered

Table 156. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Hangzhou Jiuyuan Gene Engineering Main Business

Table 158. Hangzhou Jiuyuan Gene Engineering Latest Developments

Table 159. Chengdu Baiyu Pharmaceutical Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 160. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Offered

Table 161. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Chengdu Baiyu Pharmaceutical Main Business

Table 163. Chengdu Baiyu Pharmaceutical Latest Developments

Table 164. Hebei Changshan Biochemical Pharmaceutical Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 165. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Offered

Table 166. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Hebei Changshan Biochemical Pharmaceutical Main Business

Table 168. Hebei Changshan Biochemical Pharmaceutical Latest Developments

Table 169. Changzhou Qianhong Bio-pharma Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 170. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Offered

Table 171. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Changzhou Qianhong Bio-pharma Main Business

Table 173. Changzhou Qianhong Bio-pharma Latest Developments

Table 174. Beijing SL Pharmaceutical Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 175. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Offered

Table 176. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Beijing SL Pharmaceutical Main Business

Table 178. Beijing SL Pharmaceutical Latest Developments

Table 179. Suzhou Erye Pharmaceutical Basic Information, Enoxaparin Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 180. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Offered

Table 181. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. Suzhou Erye Pharmaceutical Main Business

Table 183. Suzhou Erye Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Enoxaparin Sodium Injection

Figure 2. Enoxaparin Sodium Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Enoxaparin Sodium Injection Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Enoxaparin Sodium Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Enoxaparin Sodium Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 20 mg/0.2mL

Figure 10. Product Picture of 30 mg/0.3mL

Figure 11. Product Picture of 40 mg/0.4mL

Figure 12. Product Picture of 60 mg/0.6mL

Figure 13. Product Picture of 80 mg/0.8mL

Figure 14. Product Picture of 100 mg/1mL

Figure 15. Product Picture of 120 mg/0.8mL

Figure 16. Product Picture of 150 mg/1mL

Figure 17. Product Picture of 300mg/3mL

Figure 18. Global Enoxaparin Sodium Injection Sales Market Share by Type in 2021

Figure 19. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2017-2022)

Figure 20. Enoxaparin Sodium Injection Consumed in Hospital

Figure 21. Global Enoxaparin Sodium Injection Market: Hospital (2017-2022) & (K Units)

Figure 22. Enoxaparin Sodium Injection Consumed in Clinic

Figure 23. Global Enoxaparin Sodium Injection Market: Clinic (2017-2022) & (K Units)

Figure 24. Enoxaparin Sodium Injection Consumed in Others

Figure 25. Global Enoxaparin Sodium Injection Market: Others (2017-2022) & (K Units)

Figure 26. Global Enoxaparin Sodium Injection Sales Market Share by Application (2017-2022)

Figure 27. Global Enoxaparin Sodium Injection Revenue Market Share by Application in 2021

Figure 28. Enoxaparin Sodium Injection Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Enoxaparin Sodium Injection Revenue Market Share by Company in 2021

Figure 30. Global Enoxaparin Sodium Injection Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Enoxaparin Sodium Injection Revenue Market Share by Geographic Region in 2021

Figure 32. Global Enoxaparin Sodium Injection Sales Market Share by Region (2017-2022)

Figure 33. Global Enoxaparin Sodium Injection Revenue Market Share by Country/Region in 2021

Figure 34. Americas Enoxaparin Sodium Injection Sales 2017-2022 (K Units)

Figure 35. Americas Enoxaparin Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 36. APAC Enoxaparin Sodium Injection Sales 2017-2022 (K Units)

Figure 37. APAC Enoxaparin Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 38. Europe Enoxaparin Sodium Injection Sales 2017-2022 (K Units)

Figure 39. Europe Enoxaparin Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Enoxaparin Sodium Injection Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Enoxaparin Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 42. Americas Enoxaparin Sodium Injection Sales Market Share by Country in 2021

Figure 43. Americas Enoxaparin Sodium Injection Revenue Market Share by Country in 2021

Figure 44. United States Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Enoxaparin Sodium Injection Sales Market Share by Region in 2021

Figure 49. APAC Enoxaparin Sodium Injection Revenue Market Share by Regions in 2021

Figure 50. China Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Enoxaparin Sodium Injection Sales Market Share by Country in 2021

Figure 57. Europe Enoxaparin Sodium Injection Revenue Market Share by Country in 2021

Figure 58. Germany Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Enoxaparin Sodium Injection Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Enoxaparin Sodium Injection Revenue Market Share by Country in 2021

Figure 65. Egypt Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Enoxaparin Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Enoxaparin Sodium Injection in 2021

Figure 71. Manufacturing Process Analysis of Enoxaparin Sodium Injection

Figure 72. Industry Chain Structure of Enoxaparin Sodium Injection

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390